SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-039877
Filing Date
2017-06-14
Accepted
2017-06-14 17:31:08
Documents
1
Period of Report
2017-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4072
  Complete submission text file 0001209191-17-039877.txt   5813
Mailing Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8
Business Address 2150 ? 885 WEST GEORGIA STREET VANCOUVER A1 V6C 3E8 604-558-6536
Sierra Oncology, Inc. (Issuer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 350 E MICHIGAN AVENUE STE 500 APJOHN GROUP LLC KALAMAZOO MI 49007
Business Address C/O 350 E MICHIGAN AVENUE STE 500 APJOHN GROUP LLC KALAMAZOO MI 49007 269 349 8999
Parfet Donald R (Reporting) CIK: 0001305641 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37490 | Film No.: 17911953